Transplacental passage of nirmatrelvir in pregnant women with COVID-19

被引:1
作者
Chuang, Ming-Ta [1 ]
Su, Mei-Tsz [1 ]
Chou, Chen-Hsi [2 ]
Liang, Yu-Ling [1 ]
Tsai, Hsing-Fen [1 ]
Yu, Pei-Hsiu [1 ]
Wu, Meng-Hsing [1 ]
Ko, Wen-Chien [3 ]
Tsai, Pei-Yin [1 ,4 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Obstet & Gynecol, Natl Cheng Kung Univ Hosp, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan
[4] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Obstet & Gynecol, 138,Sheng Li Rd, Tainan 704, Taiwan
关键词
COVID-19; nirmatrelvir; Paxlovid; pregnancy; transplacental exposure; OUTCOMES; FETAL;
D O I
10.1002/ijgo.15147
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:351 / 353
页数:3
相关论文
共 8 条
[1]  
[Anonymous], US
[2]   Reproductive and developmental safety of nirmatrelvir (PF-07321332), an oral SARS-CoV-2 Mpro inhibitor in animal models [J].
Catlin, N. R. ;
Bowman, C. J. ;
Campion, S. N. ;
Cheung, J. R. ;
Nowland, W. S. ;
Sathish, J. G. ;
Stethem, C. M. ;
Updyke, L. ;
Cappon, G. D. .
REPRODUCTIVE TOXICOLOGY, 2022, 108 :56-61
[3]   Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus [J].
Chappuy, Helene ;
Treluyer, Jean-Marc ;
Rey, Elisabeth ;
Dimet, Jerome ;
Fouche, Maria ;
Firtion, Ghislaine ;
Pons, Gerard ;
Mandelbrot, Laurent .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (02) :558-562
[4]   Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 [J].
Hammond, Jennifer ;
Leister-Tebbe, Heidi ;
Gardner, Annie ;
Abreu, Paula ;
Bao, Weihang ;
Wisemandle, Wayne ;
Baniecki, MaryLynn ;
Hendrick, Victoria M. ;
Damle, Bharat ;
Simon-Campos, Abraham ;
Pypstra, Rienk ;
Rusnak, James M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (15) :1397-1408
[5]   Short-term Pregnancy Outcomes After Nirmatrelvir-Ritonavir Treatment for Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) [J].
Loza, Alexandra ;
Farias, Ryan ;
Gavin, Nicole ;
Wagner, Richard ;
Hammer, Erica ;
Shields, Andrea .
OBSTETRICS AND GYNECOLOGY, 2022, 140 (03) :447-449
[6]   An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 [J].
Owen, Dafydd R. ;
Allerton, Charlotte M. N. ;
Anderson, Annaliesa S. ;
Aschenbrenner, Lisa ;
Avery, Melissa ;
Berritt, Simon ;
Boras, Britton ;
Cardin, Rhonda D. ;
Carlo, Anthony ;
Coffman, Karen J. ;
Dantonio, Alyssa ;
Di, Li ;
Eng, Heather ;
Ferre, RoseAnn ;
Gajiwala, Ketan S. ;
Gibson, Scott A. ;
Greasley, Samantha E. ;
Hurst, Brett L. ;
Kadar, Eugene P. ;
Kalgutkar, Amit S. ;
Lee, Jack C. ;
Lee, Jisun ;
Liu, Wei ;
Mason, Stephen W. ;
Noell, Stephen ;
Novak, Jonathan J. ;
Obach, R. Scott ;
Ogilvie, Kevin ;
Patel, Nandini C. ;
Pettersson, Martin ;
Rai, Devendra K. ;
Reese, Matthew R. ;
Sammons, Matthew F. ;
Sathish, Jean G. ;
Singh, Ravi Shankar P. ;
Steppan, Claire M. ;
Stewart, Al E. ;
Tuttle, Jamison B. ;
Updyke, Lawrence ;
Verhoest, Patrick R. ;
Wei, Liuqing ;
Yang, Qingyi ;
Zhu, Yuao .
SCIENCE, 2021, 374 (6575) :1586-+
[7]   Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues [J].
Robinson, Joshua F. ;
Hamilton, Emily G. ;
Lam, Juleen ;
Chen, Hao ;
Woodruff, Tracey J. .
PLACENTA, 2020, 100 :35-44
[8]   The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis [J].
Wei, Shu Qin ;
Bilodeau-Bertrand, Marianne ;
Liu, Shiliang ;
Auger, Nathalie .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (16) :E540-E548